Trial City
Back to News
FDA: What's New, DrugsOct 9, 2026

Phase 1 Investigational New Drug (IND) Navigator

FDA's Phase 1 IND Navigator brings together resources for sponsors preparing investigational new drug applications for CDER and CBER. The page lists guidance, learning materials, procedures, manufacturing and controls resources, forms and a Phase 1 support team contact.

Why it matters: FDA's page groups application resources and support contacts relevant to preparing Phase 1 IND submissions.

Regulations and guidanceTrial conduct and operationsAI summary
Read at FDA

How does this affect your work day to day?

No comments yet.

Join the discussion